肝动脉化疗栓塞术对富血供肝转移瘤的疗效分析  

Retrospective analysis of the treatment of hypervascular hepatic metastasis with TACE

作　　者：周大勇[1] 王建华[1] 钱晟[1] 刘嵘[1] 熊壮[1] 刘凌晓[1] 

机构地区：[1]复旦大学附属中山医院介入科,上海200032

出　　处：《介入放射学杂志》2007年第3期165-167,共3页Journal of Interventional Radiology

摘　　要：目的分析肝动脉化疗栓塞术(TACE)治疗富血供肝转移瘤的疗效。方法回顾性选取TACE治疗肝转移瘤129例,估计生存率并观察临床有效率及肿瘤碘油沉积情况。结果本组病例均见畸形早显的肿瘤血管及丰富的肿瘤染色;6个月、1、3年生存率分别为100%、73．6%和26．4%;临床有效率为68．2%(88/129),无进展率为23．3%(30/129);碘油沉积良好者(Ⅰ型+Ⅱ型)占80．9%(97/129)。结论TACE是肝转移瘤良好的治疗手段,区分出富血供肿瘤有助于提高其疗效并制定合适的治疗计划。Objective To evaluate the treatment of hypervascular hepatic metastasis with TACE. Methods One hundred and twenty nine cases of hepatic metastasis treated by TACE were selected retrospectively and then analyzed the survival rate, clinical effectiveness and lipidol deposition quantity in tumor. Results Malformation of tumor vessels and rich blood supply were found in all cases of this study. The survival rates of 6 months, 1 year and 3 years were 100% ,73.6% and 26.4% respectively. The clinical effective rate was 68.2%（88/129）and no-progress rate was 23.3%（30/129）. The satisfactory lipidol deposition quantity was obtained in 80.9% （97/129）. Conclusions TACE is a favorable method for hepatic metastasis, and discerning the hypervascular subgroup could improve the treating effectiveness and be useful to make an appropriate planning.

关 键 词：肝动脉化疗栓塞术 肝转移瘤 富血供 

分 类 号：R735.7[医药卫生—肿瘤]